Last reviewed · How we verify
NCT05478291
Vitamin D Supplementation on Surrogate Markers of Atherosclerosis
NA trial testing Vitamin D supplementation in Atherosclerosis in 120 participants. Not yet recruiting.
30 June 2026
Quick facts
| Lead sponsor | Diabetes Foundation, India |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 120 |
| Start date | 1 September 2023 |
| Primary completion | 30 June 2026 |
| Estimated completion | 30 August 2026 |
Drugs / interventions tested
- Vitamin D supplementation
Conditions studied
- Atherosclerosis — all drugs for Atherosclerosis →
Sponsor
Diabetes Foundation, India
Who can join
Adults 20 to 60, any sex, with Atherosclerosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
For this study, our sample population is individuals with prediabetes, who are at an increased risk for atherosclerosis. In this proposed randomized placebo-controlled prospective trial, we would be enrolling 120 subjects with prediabetes having vitamin D deficiency. These subjects will be randomized into two groups; lifestyle modification counselling along with intervention with either vitamin D supplementation or placebo. Clinical and dietary profiles including sunlight exposure, anthropometry, glycemic and lipid profiles, fasting insulin, adiponectin, body composition (DEXA), skinfolds (4 sites), surrogate markers of atherosclerosis/inflammation (TNF-alpha, hs-CRP, Matrix Metalloproteinase-9, flow-mediated dilatation of brachial artery, pulse wave velocity, and carotid intima-mediated thickness) will be measured at week 0 and week.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05478291
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vitamin D supplementation
Trials testing the same drug.
- NCT06634316 — Sarcopenia in Patients With Heart Failure · NA · active not recruiting
- NCT05650437 — Impact of Ultraviolet Radiation on Bone Density and Muscle Strength in Postmenopausal Women · NA · completed
- NCT05916053 — Supplementation and Depressive Symptomatology Incidence Among Saudi Arabian Adults · NA · completed
- NCT04596657 — Vitamin D3 Supplementation to Prevent Respiratory Tract Infections · NA · completed
- NCT03871322 — The Vitamin K2 and D3 Intervention Trial in Children and Adolescents With the Low-energy Fractures · NA · unknown
Other recruiting trials for Atherosclerosis
Currently open trials in the same condition.
- NCT07448038 — A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vas · Phase 2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT06788431 — A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability in Patients With Acute Coronary · EARLY_PHASE1 · recruiting
- NCT06676046 — Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions · recruiting
- NCT06694012 — Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2 · recruiting
Other Diabetes Foundation, India trials
Trials by the same sponsor.
- NCT07205705 — Impact of Partially Replacing Wheat With Millets or Bengal Gram Flour in Rotis on Glycemia and Prediabetes Reversal · NA · not yet recruiting
- NCT06454773 — To Evaluate the Impact of Consumption of Bioactive Compounds Extracted From Hemp Hull and Black Pepper on Fasting Blood · Phase 3 · recruiting
- NCT06386939 — Comparison of Micro- and Macrovascular Disease(s) in People With T2D, Who Have Moderate to Severe Acanthosis Nigricans v · recruiting
- NCT06386952 — To Compare People With T2DM Who Have Double Hump Versus Who do Not Have Double Hump · recruiting
- NCT05925946 — Effect of Low-Calorie Diet and Lifestyle Intervention on Reversal of T2DM · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05478291 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Diabetes Foundation, India
- Last refreshed: 15 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05478291.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing